These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38402263)

  • 1. Bioinformatics analysis for the identification of Sprouty-related EVH1 domain-containing protein 3 expression and its clinical significance in thyroid carcinoma.
    Zhang X; Meng X; Wang P; Luan C; Wang H
    Sci Rep; 2024 Feb; 14(1):4549. PubMed ID: 38402263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPRED3 regulates the NF-κB signaling pathway in thyroid cancer and promotes the proliferation.
    Chen Z; Wang C; Li M; Cai S; Liu X
    Sci Rep; 2024 Sep; 14(1):20506. PubMed ID: 39227612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of disulfidptosis-associated genes and characterization of immune cell infiltration in thyroid carcinoma.
    Song S; Zhou J; Zhang L; Sun Y; Zhang Q; Tan Y; Zhou X; Yu J
    Aging (Albany NY); 2024 Jun; 16(11):9753-9783. PubMed ID: 38836761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
    Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
    BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma.
    Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J
    Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HSPA5 is a prognostic biomarker correlated with immune infiltrates in thyroid carcinoma.
    Dong W; Du D; Huang H
    Endokrynol Pol; 2022; 73(4):680-689. PubMed ID: 36059163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased SEMA6B expression as a potential prognostic and immune cell infiltration biomarker in thyroid cancer patients.
    Lei Q; Wang Y; Li J; Wang S; Hu Y; Duan L; Huo Y; Wu Y; Liu H
    Aging (Albany NY); 2023 May; 15(9):3572-3585. PubMed ID: 37155149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration and validation of key genes associated with early lymph node metastasis in thyroid carcinoma using weighted gene co-expression network analysis and machine learning.
    Liu Y; Yin Z; Wang Y; Chen H
    Front Endocrinol (Lausanne); 2023; 14():1247709. PubMed ID: 38144565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of BTNL9 as a prognostic biomarker correlated with immune infiltrations in thyroid cancer.
    Zhang L; Yu S; Hong S; Xiao X; Liao Z; Li Y; Xiao H
    BMC Med Genomics; 2023 Oct; 16(1):234. PubMed ID: 37798795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TTN mutations predict a poor prognosis in patients with thyroid cancer.
    Han X; Chen J; Wang J; Xu J; Liu Y
    Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35766333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen-related genes for thyroid cancer prognosis, immune infiltration, staging, and drug sensitivity.
    Zhang L; Zhou M; Gao X; Xie Y; Xiao J; Liu T; Zeng X
    BMC Cancer; 2023 Oct; 23(1):1048. PubMed ID: 37907864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of hub genes in thyroid carcinoma to predict prognosis by integrated bioinformatics analysis.
    Pan Y; Wu L; He S; Wu J; Wang T; Zang H
    Bioengineered; 2021 Dec; 12(1):2928-2940. PubMed ID: 34167437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNAJB11 predicts a poor prognosis and is associated with immune infiltration in thyroid carcinoma: a bioinformatics analysis.
    Sun R; Yang L; Wang Y; Zhang Y; Ke J; Zhao D
    J Int Med Res; 2021 Nov; 49(11):3000605211053722. PubMed ID: 34727750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Key molecules associated with thyroid carcinoma prognosis: A study based on transcriptome sequencing and GEO datasets.
    Bai M; Ke S; Yu H; Xu Y; Yu Y; Lu S; Wang C; Huang J; Ma Y; Dai W; Wu Y
    Front Immunol; 2022; 13():964891. PubMed ID: 36059514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of plasma complement factor B (CFB) in thyroid carcinoma.
    Wu P; Shi J; Sun W; Zhang H
    Bioengineered; 2021 Dec; 12(2):12854-12866. PubMed ID: 34898340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mining Prognostic Biomarkers of Thyroid Cancer Patients Based on the Immune-Related Genes and Development of a Reliable Prognostic Risk Model.
    Fei H; Han X; Wang Y; Li S
    Mediators Inflamm; 2023; 2023():6503476. PubMed ID: 37554551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of PANoptosis-related genes as prognostic indicators of thyroid cancer.
    Xie D; Huang L; Li C; Wu R; Zheng Z; Liu F; Cheng H
    Heliyon; 2024 Jun; 10(11):e31707. PubMed ID: 38845990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of a Novel Prognosis Model with Tumor Mutation Burden and Tumor-Infiltrating Immune Cells in Thyroid Carcinoma.
    Zhang S; Chen S; Wang Y; Zhan Y; Li J; Nong X; Gao B
    Front Genet; 2021; 12():744304. PubMed ID: 34976004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy.
    Hong K; Cen K; Chen Q; Dai Y; Mai Y; Guo Y
    Front Immunol; 2023; 14():1128390. PubMed ID: 36761753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA H19 is a potential biomarker and correlated with immune infiltration in thyroid carcinoma.
    Sahin Y
    Clin Exp Med; 2023 Jul; 23(3):841-851. PubMed ID: 35810257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.